- Home
- DTIL vs FSEA Comparison
DTIL vs FSEA Comparison
Compare DTIL & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- FSEA
- Stock Information
- Founded
- DTIL 2006
- FSEA 1890
- Country
- DTIL United States
- FSEA United States
- Employees
- DTIL N/A
- FSEA N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- DTIL Health Care
- FSEA Finance
- Exchange
- DTIL Nasdaq
- FSEA Nasdaq
- Market Cap
- DTIL 43.3M
- FSEA 51.2M
- IPO Year
- DTIL 2019
- FSEA N/A
- Fundamental
- Price
- DTIL $4.68
- FSEA $11.55
- Analyst Decision
- DTIL Strong Buy
- FSEA
- Analyst Count
- DTIL 3
- FSEA 0
- Target Price
- DTIL $37.67
- FSEA N/A
- AVG Volume (30 Days)
- DTIL 132.7K
- FSEA 6.8K
- Earning Date
- DTIL 03-26-2025
- FSEA 05-09-2025
- Dividend Yield
- DTIL N/A
- FSEA N/A
- EPS Growth
- DTIL N/A
- FSEA N/A
- EPS
- DTIL 1.04
- FSEA N/A
- Revenue
- DTIL $68,696,000.00
- FSEA $15,874,000.00
- Revenue This Year
- DTIL N/A
- FSEA N/A
- Revenue Next Year
- DTIL $58.46
- FSEA N/A
- P/E Ratio
- DTIL $4.51
- FSEA N/A
- Revenue Growth
- DTIL 40.98
- FSEA 70.41
- 52 Week Low
- DTIL $3.61
- FSEA $8.25
- 52 Week High
- DTIL $15.97
- FSEA $11.69
- Technical
- Relative Strength Index (RSI)
- DTIL 44.71
- FSEA 68.73
- Support Level
- DTIL $4.25
- FSEA $11.36
- Resistance Level
- DTIL $4.99
- FSEA $11.69
- Average True Range (ATR)
- DTIL 0.40
- FSEA 0.15
- MACD
- DTIL -0.04
- FSEA 0.01
- Stochastic Oscillator
- DTIL 34.01
- FSEA 79.71
Stock Price Comparison Chart: DTIL vs FSEA
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.